Talking About Tumors with Ryann and Ryan - A medical oncology podcast

03_01 The era of immune checkpoint inhibitors

March 27, 2023 Talking About Tumors Season 3 Episode 1
Talking About Tumors with Ryann and Ryan - A medical oncology podcast
03_01 The era of immune checkpoint inhibitors
Show Notes

  1. History of Immunotherapy
  2. Modern immune checkpoint inhibitors (ICIs)
  3. Unique considerations with ICIs
  4. Immune related adverse events and immortal time bias in observational studies



As always, citations, and sources include education from our respective training programs, the Devita textbook, and  We highly encourage review of guidelines published by ASCO, ESMO and other organizations local to your practice.

DeVita, Vincent T., Jr., Theodore S. Lawrence, and Steven A. Rosenberg. Devita, Hellman, and Rosenberg's Cancer: Principles & Practice of Oncology. 10th edition. Philadelphia: Wolters Kluwer, 2015. Waltham, MA: Wolters Kluwer.

Some highlighted references recommended to read related to this specific episode:

1.          Yadav K, Lewis RJ. JAMA. 2021;325(7):686-687. doi:10.1001/JAMA.2020.9151

2.           Holstead RG et al. Melanoma Res. 2021;31(3):258-263. doi:10.1097/CMR.0000000000000736

3.           Kartolo A et al. J Immunother. 2021;44(4):167-174. doi:10.1097/CJI.0000000000000360

4.           Dolladille C et al. JAMA Oncol. 2020;6(6):865-871. doi:10.1001/JAMAONCOL.2020.0726

5.           Mahmood SS et al. J Am Coll Cardiol. 2018;71(16):1755-1764. doi:10.1016/J.JACC.2018.02.037

6.           Coley WB. Proc R Soc Med. 1910;3(Surg Sect):1. doi:10.1177/003591571000301601

7.           Larkin J  et al.  NEJM. 2019;381(16):1535-1546. doi:10.1056/NEJMOA1910836/

8.           Wolchok JD  et al. Lancet Oncol. 2010;11(2):155-164. doi:10.1016/S1470-2045(09)70334-1

9.           Hodi FS et al. NEJM. 2010;363(8):711-723. doi:10.1056/NEJMOA1003466/SUPPL_FILE/

10.        Brahmer J et al. JCO. 2018;36(17):1714-1768 doi:10.1200/JCO.2017.77.6385



Talking about Tumors with Ryan and Ryann is not medical advice.  We have received no funding in relation to the information discussed within this episode and have no financial conflicts of interest to disclose.  All opinions are those of whoever stated them.  We have compiled this podcast to serve as an introduction to the field of medical oncology for post-graduate trainees interested in the topic. 


Hematology/Oncology, evidence based medicine, education, chemotherapy, immunotherapy, medical oncology